Pathstone Holdings »

Eledon Pharmaceuticals shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Eledon Pharmaceuticals (ELDN) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Eledon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eledon Pharmaceuticals held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eledon Pharmaceuticals by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2024-03-31 $27k 13k 2.06
2023-12-31 $24k 13k 1.80

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)
Crowdstrike Hldgs Cl A (CRWD)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Pathstone Holdings

Top funds holding Eledon Pharmaceuticals

BVF
Armistice Capital
Vanguard Group
Woodline Partners
Ensign Peak Advisors
Geode Capital Management
CM Management
Susquehanna International
Jmac Enterprises
Ingalls & Snyder
Schonfeld Strategic Advisors
Northern Trust
BlackRock
Marco Investment Management
Citadel Advisors

View all funds holding Eledon Pharmaceuticals